<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00234273</url>
  </required_header>
  <id_info>
    <org_study_id>DCIC 03 09</org_study_id>
    <nct_id>NCT00234273</nct_id>
  </id_info>
  <brief_title>APAD2: Effects of Rehabilitation Programme in Adapted Physical Activity (APA) Among Type 2 Diabetics</brief_title>
  <official_title>Effects Rehabilitation Programme in Adapted Physical Activity (APA) Among Type 2 Diabetics Persons</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The principal objective is to assess and analyze the effects of a six month programme in
      Adapted Physical Activity (APA) on physical activity, compliance, and insulin resistance
      among type 2 diabetics.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Clinical trial with direct individual profit. Study phase 2. Study center: University
      Hospital Grenoble Principal investigator: Pr. Serge HALIMI Sponsor: University Hospital
      Grenoble

      The principal objective is to assess and analyze the effects of a six month programme in
      Adapted Physical Activity (APA) on physical activity, compliance, and insulin resistance
      among type 2 diabetics.

      Secondary objectives are to assess and analyze the effects of a six month programme in APA
      of:

        -  arterial tension

        -  weight, body composition and abdominal perimeter

        -  quality of life

        -  treatment dosage

        -  number of hospitalisation thick a diabetes complication acute for one year and for each
           patient Compare two exercise's intensity: first lactate threshold (SL1) and crossover
           (PCGL).

      Inclusion criteria:

        -  type 2 diabetics

        -  age &gt; 40 years

        -  first education in Education Diabetics Department of University Hospital Grenoble

        -  sedentary patients

        -  HbA1c &gt; 7%-

        -  BMI &gt; 25

        -  to be affiliate disease assurance

        -  to give consent written and inform

      Judgment criteria for physical activity compliance:

        -  leisure time physical activity: Modifiable Activity Questionnaire

        -  training note-book

      Judgment criteria for resistance insulin:

        -  Crossover (PCGL)

        -  HOMA and FIRI index

        -  HbA1c

      Programme test: Rehabilitation programme in Adapted Physical Activity (APA)

      Programme test period: 6 months

      Study total period: 28 months

      Study period for each patient: 18 months

      Safety criteria: clinical compendium undesirable events
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    recrutment
  </why_stopped>
  <start_date>November 2004</start_date>
  <completion_date type="Actual">June 2008</completion_date>
  <primary_completion_date type="Actual">June 2008</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Increase physical activity compliance long-term</measure>
    <time_frame>6 months after the beginning of the program</time_frame>
    <description>Modifiable Activity Questionnaire (MAQ</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lessen insulin resistance</measure>
    <time_frame>6 months after the beginning of the program</time_frame>
    <description>HOMA (Homeo-stasis model assessment), HbA1c, PCGL</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improve the quality of life</measure>
    <time_frame>6 months after the beginning of the program</time_frame>
    <description>Short Form-36 Health Survey Questionnary (SF-36)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improve the arterial tension</measure>
    <time_frame>6 months after the beginning of the program</time_frame>
    <description>arterial tension</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lessen the weight</measure>
    <time_frame>6 months after the beginning of the program</time_frame>
    <description>weight</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>NIDDM</condition>
  <arm_group>
    <arm_group_label>Therapeutic education combining dietary and rehabilitation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Therapeutic education combining dietary and rehabilitation (APA)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Therapeutic education primarily focused on dietary</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Therapeutic education primarily focused on dietary</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Rehabilitation programme in Adapted Physical Activity (APA)</intervention_name>
    <arm_group_label>Therapeutic education combining dietary and rehabilitation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Therapeutic education primarily focused on dietary</intervention_name>
    <arm_group_label>Therapeutic education combining dietary and rehabilitation</arm_group_label>
    <arm_group_label>Therapeutic education primarily focused on dietary</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 2 diabetics

          -  Age &gt; 40

          -  First education in the Education Diabetics Department of the University Hospital
             Grenoble

          -  Sedentary patients

          -  Hemoglobin A1c (HbA1c) &gt; 7%

          -  Body mass index (BMI) &gt; 25

          -  To be affiliated with disease assurance

          -  To give written and informed consent

        Exclusion Criteria:

          -  Foot sore &lt; six months

          -  Renal disease - proteinuria stage

          -  Contraindication for exercise

          -  VO2 max &gt; 120% Wassermann standard

          -  Coronary pathology non-stabilization

          -  Arteriopathy stage 2 non-compensation

          -  Osteo-articular crippling problem

          -  Geographically distant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>HALIMI Serge</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut National de la Santé Et de la Recherche Médicale, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Halimi S. Therapeutic strategies for type 2 diabetes. Rev Prat HALIMI</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut National de la Santé Et de la Recherche Médicale, France</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Endocrinology, Diabetology and Nutrition - University Hospital of Grenoble</name>
      <address>
        <city>Grenoble</city>
        <state>Rhone-alpes</state>
        <zip>38000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Endocrinology, Diabetology and Nutrition</name>
      <address>
        <city>Grenoble</city>
        <state>Rhône-Alpes</state>
        <zip>38000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Endocrinology, Diabetology and Nutrition Department - University Hospital of Grenoble</name>
      <address>
        <city>Grenoble</city>
        <zip>38000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HALIMI Serge</name>
      <address>
        <city>Grenoble</city>
        <zip>38000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi</url>
    <description>PubMed</description>
  </link>
  <results_reference>
    <citation>Bouvard S, Faure P, Roucard C, Favier A, Halimi S. Characterization of free radical defense system in high glucose cultured HeLa-tat cells: consequences for glucose-induced cytotoxicity. Free Radic Res. 2002 Sep;36(9):1017-22.</citation>
    <PMID>12448827</PMID>
  </results_reference>
  <results_reference>
    <citation>Halimi S, Wion-Barbot N, Lambert S, Benhamou P. [Self-monitoring of blood glucose in type 2 diabetic patients. What could we propose according to their treatment?]. Diabetes Metab. 2003 Apr;29(2 Pt 2):S26-30. Review. French.</citation>
    <PMID>12746623</PMID>
  </results_reference>
  <results_reference>
    <citation>Halimi S. [Therapeutic strategies for type 2 diabetes]. Rev Prat. 2003 May 15;53(10):1079-85. Review. French.</citation>
    <PMID>12846028</PMID>
  </results_reference>
  <results_reference>
    <citation>Halimi S. [Is a new therapeutic class justified in the treatment of type 2 diabetes?]. Ann Endocrinol (Paris). 2002 Apr;63(2 Pt 2):1S7-11. Review. French.</citation>
    <PMID>12037511</PMID>
  </results_reference>
  <results_reference>
    <citation>Halimi S, Charpentier G, Grimaldi A, Grenier JL, Baut F, Germain B, Magnette J. Effect on compliance, acceptability of blood glucose self-monitoring and HbA(1c) of a self-monitoring system developed according to patient's wishes. The ACCORD study. Diabetes Metab. 2001 Dec;27(6):681-7.</citation>
    <PMID>11852377</PMID>
  </results_reference>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 5, 2005</study_first_submitted>
  <study_first_submitted_qc>October 5, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 6, 2005</study_first_posted>
  <last_update_submitted>June 18, 2013</last_update_submitted>
  <last_update_submitted_qc>June 18, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 19, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Adapted Physical Activity</keyword>
  <keyword>Quality of life</keyword>
  <keyword>cardiovascular risk</keyword>
  <keyword>teaching</keyword>
  <keyword>Directly Observed Therapy</keyword>
  <keyword>Physical activity</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

